- Home » News and EventsPage 11
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion
May 20, 2019
Catalent, Inc. (NYSE: CTLT) today announced that it has completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies.
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Apr 15, 2019
Catalent, Inc. (NYSE: CTLT) and Paragon Bioservices, Inc. today announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.
Triphase Initiates Phase 1 Clinical Trial of B-cell Lymphoma Treatment
Apr 1, 2019
Triphase Accelerator Corporation and Catalent today announced that Triphase Accelerator’s TRPH-222, an anti-CD22 antibody-drug conjugate (ADC) for the treatment of patients with lymphoma, has been dosed in the first patient in a Phase 1 clinical trial.
Catalent Biologics to Present on Tech Transfer, Biomanufacturing and Aseptic Processing at INTERPHEX
Mar 26, 2019
Catalent Pharma Solutions today announced that two of its manufacturing experts will present at the INTERPHEX Conference and Exhibition, taking place at the Javits Center, New York City, on April 2-4, 2019.
Advances in Biologics Development to be Discussed at Symposium Hosted by the Catalent Applied Drug Delivery Institute at the UCSF Mission Bay Campus
Mar 19, 2019
The Catalent Applied Drug Delivery Institute today announced that it is to hold a one-day symposium entitled “Advances in Biologics Development and Delivery”.
Techniques for Achieving High Dose Accuracy to be Presented by Catalent Biologics Experts at ISPE Aseptic Conference
Mar 12, 2019
Catalent Pharma Solutions today announced that two of its scientific experts will present at the International Society for Pharmaceutical Engineering (ISPE) Aseptic Conference.
Solutions for Assay Automation to be Presented by Catalent Biologics at BEBPA US Bioassay Conference
Feb 19, 2019
Catalent Pharma Solutions today announced that Michael Sadick, Ph.D., Principal Scientist, Catalent Biologics, will present at the annual US Bioassay Conference of the BioPharmaceutical Emerging Best Practices Association (BEBPA).
Debate on Patient-Focused Biologic Design to be Led by Catalent at Drug Delivery Partnerships
Jan 24, 2019
Catalent Pharma Solutions today announced that Cornell Stamoran, Ph.D. will present at the 23rd annual Drug Delivery Partnerships (DDP) conference.
Assay Automation to be Presented by Catalent Biologics Expert at WCBP Symposium
Jan 17, 2019
Catalent today announced that one of its scientific experts will present at CASSS’s WCBP conference, the 23rd Symposium on the Interface of Regulatory & Analytical Sciences for Biotechnology Health Products.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.